TipRanks
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
ENSC
Ensysce Biosciences
RESEARCH TOOLSreports
Want to see ENSC full AI Analyst Report?

Ensysce Biosciences (ENSC) Income Statement

322 Followers

Ensysce Biosciences Income Statement

Last quarter (Q2 2026), Ensysce Biosciences's total revenue was $1.16M, an increase of Infinity% from the same quarter last year. In Q2, Ensysce Biosciences's net income was $-2.57M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 10.24M$ 6.73M$ 10.72M$ 24.22M$ 19.87M
Depreciation and Amortization
$ 6.53K$ 0.00$ 0.00$ 0.00$ 151.00
EBITDA
$ -10.15M$ -6.70M$ -10.27M$ -24.10M$ -27.85M
Operating Income
$ -10.24M$ -6.73M$ -10.72M$ -24.22M$ -19.87M
Other Income/Expenses
$ 64.76K$ -1.26M$ 91.91K$ 14.41K$ -9.28M
Pretax Income
$ -10.18M$ -7.99M$ -10.63M$ -24.21M$ -29.15M
Net Income
$ -10.18M$ -7.99M$ -10.61M$ -24.17M$ -29.08M
Per Share Metrics
Basic EPS
$ -3.98$ -4.57$ -4.69$ -139.44$ -355.68
Diluted EPS
$ -3.98$ -4.57$ -4.69$ -139.44$ -355.68
Weighted Average Shares Outstanding
 2.56M 1.75M 2.26M 179.93K 84.02K
Weighted Average Shares Outstanding (Diluted)
 25.57M 1.75M 2.26M 179.93K 84.02K
Currency in USD

Ensysce Biosciences Earnings and Revenue History